NOTE AND WARRANT PURCHASE AGREEMENT
This
Note
and Warrant Purchase Agreement, dated as of ____________, 2007, (this
“Agreement”)
is
entered into by and among New Design Cabinets, Inc., a Nevada corporation (the
“Company”),
and
the persons and entities listed on signature page hereto (each an “Investor”
and,
collectively, the “Investors”).
RECITALS
A. On
the
terms and subject to the conditions set forth herein, each Investor is willing
to purchase from the Company, and the Company is willing to sell to such
Investor, a convertible promissory note in the principal amount set forth
opposite such Investor’s name on the signature page hereto, together with a
related warrant to acquire shares of the Company’s common stock, $.001 par value
(the “Common
Stock”).
B. Capitalized
terms not otherwise defined herein shall have the meaning set forth in the
form
of Note (as defined below) attached hereto as Exhibit
A.
AGREEMENT
NOW
THEREFORE, in consideration of the foregoing, and the representations,
warranties, and conditions set forth below, the parties hereto, intending to
be
legally bound, hereby agree as follows:
1. The
Notes and Warrant.
(a) Issuance
of Notes and Warrants.
At the
Closing (as defined below), the Company agrees to issue and sell to each of
the
Investors, and, subject to all of the terms and conditions hereof, each of
the
Investors severally agrees to purchase a convertible promissory note in the
form
of Exhibit
A
hereto
(each, a “Note”
and,
collectively, the “Notes”)
in the
principal amount set forth opposite the respective Investor’s name on the
signature page hereto. The obligations of the Investors to purchase Notes are
several and not joint.
(b) In
consideration for the purchase by the Investors of the Notes, the Company will
issue to each Investor a warrant in the form attached hereto as Exhibit
B
(each, a
“Warrant”
and,
collectively, the “Warrants”)
to
purchase up to a number of shares of Common Stock equal to the number of shares
set forth opposite each Investor’s name on the signature page
hereto.
(c) Delivery.
The
sale and purchase of the Notes and Warrants shall take place at a closing (the
“Closing”)
to be
held at such place and time as the Company and the Investors may determine
(the
“Closing
Date”).
Within five (5) days of the Closing, the Company will deliver to each of the
Investors the respective Note and Warrant to be purchased by such Investor,
against receipt by the Company of the corresponding purchase price set forth
on
the signature page hereto
(the “Purchase
Price”).
Each
of the Notes and Warrants will be registered in such Investor’s name in the
Company’s records.
2. Representations
and Warranties of the Company.
The
Company represents and warrants to each Investor that:
(a) Due
Incorporation, Qualification, etc.
The
Company (i) is a corporation duly organized, validly existing and in good
standing under the laws of its state of incorporation; (ii) has the power and
authority to own, lease and operate its properties and carry on its business
as
now conducted; and (iii) is duly qualified, licensed to do business and in
good
standing as a foreign corporation in each jurisdiction where the failure to
be
so qualified or licensed could reasonably be expected to have a Material Adverse
Effect.
(b) Authority.
The
execution, delivery and performance by the Company of each Transaction Document
to be executed by the Company and the consummation of the transactions
contemplated thereby (i) are within the power of the Company and (ii) have
been duly authorized by all necessary actions on the part of the
Company.
(c) Enforceability.
Each
Transaction Document executed, or to be executed, by the Company has been,
or
will be, duly executed and delivered by the Company and constitutes, or will
constitute, a legal, valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms, except as limited by
bankruptcy, insolvency or other laws of general application relating to or
affecting the enforcement of creditors’ rights generally and general principles
of equity.
(d) Non-Contravention.
The
execution and delivery by the Company of the Transaction Documents executed
by
the Company and the performance and consummation of the transactions
contemplated thereby do not and will not (i) violate the Company’s Articles of
Incorporation or Bylaws, as amended, as the case may be (“Charter
Documents”),
or
any material judgment, order, writ, decree, statute, rule or regulation
applicable to the Company; (ii) violate any provision of, or result in the
breach or the acceleration of, or entitle any other Person to accelerate
(whether after the giving of notice or lapse of time or both), any material
mortgage, indenture, agreement, instrument or contract to which the Company
is a
party or by which it is bound; or (iii) result in the creation or
imposition of any lien upon any property, asset or revenue of the Company or
the
suspension, revocation, impairment, forfeiture, or nonrenewal of any material
permit, license, authorization or approval applicable to the Company, its
business or operations, or any of its assets or properties.
(e) Approvals.
Other
than in connection with the requisite filings under applicable “Blue Sky” laws
and the filing with the Securities and Exchange Commission (the “SEC”)
of a
Form D, the Company is not required to obtain any consent, authorization or
order of, or make any filing or registration with, any court, governmental
agency or any regulatory or self-regulatory agency or any other Person in order
for it to execute, deliver or perform any of its obligations under or
contemplated by this Agreement, in each case in accordance with the terms hereof
or thereof.
(f) No
Violation or Default.
The
Company is not in violation of or in default with respect to (i) its
Charter Documents or any material judgment, order, writ, decree, statute, rule
or regulation applicable to such Person; or (ii) any material mortgage,
indenture, agreement, instrument or contract to which such Person is a party
or
by which it is bound (nor is there any waiver in effect which, if not in effect,
would result in such a violation or default), where, in each case, such
violation or default, individually, or together with all such violations or
defaults, could reasonably be expected to have a Material Adverse
Effect.
-2-
(g) Litigation.
No
actions (including, without limitation, derivative actions), suits, proceedings
or investigations are pending or, to the knowledge of the Company, threatened
against the Company at law or in equity in any court or before any other
governmental authority that if adversely determined (i) would (alone or in
the aggregate) have a Material Adverse Effect or (ii) seeks to enjoin,
either directly or indirectly, the execution, delivery or performance by the
Company of the Transaction Documents or the transactions contemplated
thereby.
(h) Taxes.
Within
the times and in the manner prescribed by law, the Company has filed all
federal, state and local tax returns required by law and has paid all taxes,
assessments and penalties due and payable.
(i) OTCBB
Compliance.
The
Company is in compliance with all requirements for, and its Common Stock is
quoted on the Electronic Over-the-Counter Bulletin Board system.
(j) SEC
Reports.
The
Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it with the SEC (the “SEC
Documents”)
pursuant to the reporting requirements of the Securities Exchange Act of 1934,
as amended (the “Exchange
Act”).
As of
their respective dates, the financial statements of the Company included in
the
SEC Documents complied as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC
with
respect thereto. Such financial statements have been prepared in accordance
with
generally accepted accounting principles, consistently applied, during the
periods involved (except (i) as may be otherwise indicated in such financial
statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be condensed or
summary statements) and fairly present in all material respects the financial
position of the Company as of the dates thereof and the results of its
operations and cash flows for the periods then ended (subject, in the case
of
unaudited statements, to normal year-end audit adjustments).
(k) Capitalization.
The
authorized capital stock of the Company currently consists of 250,000,000 shares
of Common Stock and 50,000,000 shares of preferred stock, $.001 par value (the
“Preferred
Stock”),
of
which 55,000,000 shares of Common Stock and no shares of Preferred Stock are
issued and outstanding. Except as set forth below, there are no outstanding
shares of Preferred Stock, options, rights, warrants, debentures, instruments,
convertible securities or other agreements or commitments obligating the Company
to issue any additional shares of its capital stock of any class. Concurrently
with the Closing, the Company will close a private placement of Common Stock
of
up to $10.0 million (the “Private
Placement”).
Assuming the Private Placement is fully subscribed for, and that all $10.0
million of Common Stock is purchased by the investors, immediately after the
closing of the Private Placement, the investors in the Private Placement will
receive an aggregate of 14,285,714 shares of Common Stock and warrants to
purchase 7,142,857 shares of Common Stock. In addition, concurrently with the
Closing, the Company will close a private placement of Series A preferred stock,
$.001 par value (the “Series
A Preferred
Stock”)
for
$5.0 million (the “Series
A Private Placement”).
The
investor in the Series A Private Placement will receive an aggregate of
7,142,857 shares of Series A Preferred Stock and a warrant to purchase 1,785,714
shares of Common Stock. As a result, after giving effect to the Private
Placement and the Series A Private Placement, there will be 69,285,714 shares
of
Common Stock, 7,142,857 shares of Series A Preferred Stock and 8,928,571 shares
of Common Stock underlying warrants issued and outstanding.
-3-
(l) General
Solicitation.
Neither
the Company, nor any of its affiliates, nor any Person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D promulgated under the Securities Act) in
connection with the offer or sale of the Notes or Warrants.
(m) Accuracy
of Information Furnished.
None of
the Transaction Documents and none of the other certificates, statements or
information furnished to Investors by or on behalf of the Company in connection
with the Transaction Documents or the transactions contemplated thereby contains
or will contain any untrue statement of a material fact or omits or will omit
to
state a material fact necessary to make the statements therein, in light of
the
circumstances under which they were made, not misleading.
(n) Issuance
of the Securities.
The
Notes and Warrants are duly authorized and, upon issuance in accordance with
the
terms hereof, will be duly and validly issued, fully paid and nonassessable,
free from all taxes, liens and charges with respect to the issue thereof. The
Common Stock underlying Notes and Warrants have been duly authorized and, when
issued and paid for in accordance with the Transaction Documents, will be duly
and validly issued, fully paid and nonassessable, free and clear of all taxes,
liens and charges with respect to the issue thereof. The Company has reserved
from its duly authorized capital stock the maximum number of shares of Common
Stock issuable pursuant to the Notes and Warrants in order to issue the full
number of such shares of Common Stock underlying the Notes and Warrants as
are
or may become issuable in accordance with the terms of the Notes and the
Warrants. Upon receipt of the Common Stock underlying the Notes and Warrants,
the Investors will have good and marketable title to such shares of Common
Stock.
3. Representations
and Warranties of U.S. Investors.
Each
Investor that is a U.S. Person (as defined under Regulation S of the Securities
Act), for that Investor alone, represents and warrants to the Company upon
the
acquisition of the Note and the Warrants as follows:
(a) Binding
Obligation.
Such
Investor has full legal capacity, power and authority to execute and deliver
this Agreement and to perform its obligations hereunder. Each of this Agreement,
the Note and the Warrant issued to such Investor is a valid and binding
obligation of the Investor, enforceable in accordance with their terms, except
as limited by bankruptcy, insolvency or other laws of general application
relating to or affecting the enforcement of creditors’ rights generally and
general principles of equity.
-4-
(b) Securities
Law Compliance.
Such
Investor has been advised that the Note, the Warrant and the underlying
securities have not been registered under the Securities Act, or any state
securities laws and, therefore, cannot be resold unless they are registered
under the Securities Act and applicable state securities laws or unless an
exemption from such registration requirements is available. Such Investor has
not been formed solely for the purpose of making this investment and is
purchasing the Note or Warrant to be acquired by such Investor hereunder for
its
own account for investment, not as a nominee or agent, and not with a view
to,
or for resale in connection with, the distribution thereof. Such Investor has
such knowledge and experience in financial and business matters that such
Investor is capable of evaluating the merits and risks of such investment,
is
able to incur a complete loss of such investment and is able to bear the
economic risk of such investment for an indefinite period of time. Such Investor
is an accredited investor as such term is defined in Rule 501 of
Regulation D under the Securities Act.
(c) Access
to Information.
Such
Investor acknowledges that the Company has given such Investor access to the
corporate records and accounts of the Company and to all information in its
possession relating to the Company, has made its officers and representatives
available for interview by such Investor, and has furnished such Investor with
all documents and other information required for such Investor to make an
informed decision with respect to the purchase of the Note and the
Warrant.
(d) Independent
Nature of Investors' Obligations and Rights.
The
obligations of each Investor under any Transaction Document are several and
not
joint with the obligations of any other Investor, and no Investor shall be
responsible in any way for the performance of the obligations of any other
Investor under any Transaction Document. Nothing contained herein or in any
other Transaction Document, and no action taken by any Investor pursuant hereto
or thereto, shall be deemed to constitute the Investors as a partnership, an
association, a joint venture or any other kind of entity, or create a
presumption that the Investors are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the
Transaction Documents. Each Investor confirms that it has independently
participated in the negotiation of the transaction contemplated hereby with
the
advice of its own counsel and advisors. Each Investor shall be entitled to
independently protect and enforce its rights, including, without limitation,
the
rights arising out of this Agreement or out of any other Transaction Documents,
and it shall not be necessary for any other Investor to be joined as an
additional party in any proceeding for such purpose.
4. Representations
and Warranties of Non-U.S. Investors.
Each
Investor that is not a U.S. Person (as defined under Regulation S of the
Securities Act), for that Investor alone, represents and warrants to the Company
upon the acquisition of the Note and the Warrant as follows:
(a) Binding
Obligation.
Such
Investor has full legal capacity, power and authority to execute and deliver
this Agreement and to perform its obligations hereunder. Each of this Agreement,
the Note and the Warrant issued to such Investor is a valid and binding
obligation of the Investor, enforceable in accordance with their terms, except
as limited by bankruptcy, insolvency or other laws of general application
relating to or affecting the enforcement of creditors’ rights generally and
general principles of equity.
-5-
(b) Securities
Law Compliance.
The
Investor is not purchasing the Note or the Warrant for the account or benefit
of
any person, entity, group or organization that resides in the United States
or
has a place of business in the United States. The Investor did not receive
an
offer to subscribe for the Note or Warrant in the United States, and this
Agreement is being executed and entered into outside of the United States.
The
Investor agrees to transfer the Note, the Warrant and the shares of Common
Stock
underlying the Note and Warrant only in accordance with the provisions of
Regulation S promulgated under the Securities Act, pursuant to registration
under the Securities Act or pursuant to an available exemption from registration
under the Securities Act. Any transfer in violation of the preceding sentence
will be null and void and the Company will not recognize any such attempted
transfer. The undersigned acknowledges that the securities are characterized
as
“restricted securities” under U.S. federal securities laws and may be resold
without registration under the Securities Act only in certain limited
circumstances. All certificates representing such securities will bear legends
to this effect.
(c) Access
to Information.
Such
Investor acknowledges that the Company has given such Investor access to the
corporate records and accounts of the Company and to all information in its
possession relating to the Company, has made its officers and representatives
available for interview by such Investor, and has furnished such Investor with
all documents and other information required for such Investor to make an
informed decision with respect to the purchase of the Note and the
Warrant.
(d) Independent
Nature of Investors' Obligations and Rights.
The
obligations of each Investor under any Transaction Document are several and
not
joint with the obligations of any other Investor, and no Investor shall be
responsible in any way for the performance of the obligations of any other
Investor under any Transaction Document. Nothing contained herein or in any
other Transaction Document, and no action taken by any Investor pursuant hereto
or thereto, shall be deemed to constitute the Investors as a partnership, an
association, a joint venture or any other kind of entity, or create a
presumption that the Investors are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the
Transaction Documents. Each Investor confirms that it has independently
participated in the negotiation of the transaction contemplated hereby with
the
advice of its own counsel and advisors. Each Investor shall be entitled to
independently protect and enforce its rights, including, without limitation,
the
rights arising out of this Agreement or out of any other Transaction Documents,
and it shall not be necessary for any other Investor to be joined as an
additional party in any proceeding for such purpose.
-6-
5. Registration
Rights.
(a) Registration
Statement.
Upon the
consummation of the PIPE (as defined in the Note), the Company will file a
registration statement (the “Registration
Statement”)
covering, for the Investor, 100% of such Investor’s Common Stock issuable upon
conversion of the Repayment Amount (if any), and the Common Stock issuable
upon
exercise of the Warrant no later than thirty (30) calendar days after the
Company closes the PIPE (the “Filing
Date”),
except
that if the SEC limits the number of securities that may be registered on the
Registration Statement, such number of securities shall be cutback (in the
following order) to comply with any such limitation imposed by the SEC: (i)
shares of Common Stock underlying any and all warrants to be registered, (ii)
Common Stock and (iii) shares of Common Stock underlying Series A Preferred
Stock. Any required cutbacks shall be applied to the Investors pro-rata in
accordance with the number of securities sought to be included in such
Registration Statement. The Company shall use its best efforts to have the
Registration Statement declared effective by the SEC as soon as possible after
the Filing Date, but in any event no later that one hundred fifty (150) calendar
days after the closing of the PIPE.
(b) Penalty.
If the
Registration Statement is not filed within thirty (30) calendar days of the
closing of the PIPE or is not declared effective by the SEC for any reason
within one hundred fifty (150) calendar days after the closing of the PIPE,
the
Company will be required to pay the Investor an amount (the “Periodic
Amount”)
equal
to 1.5% of the principal sum of the Note for each thirty (30) day period (pro
rated for a shorter period), in each case until the Registration Statement
is
filed or declared effective, as the case may be. In no event will the aggregate
Periodic Amounts exceed 10% of the principal sum of the Notes. Periodic Amount
payments shall be made by the Company to the Investor if effectiveness of the
Registration Statement is suspended for more than thirty (30) consecutive days.
In no event shall the Company be liable for liquidated damages as to any shares
of Common Stock or any shares of Common Stock underlying the Warrants which
are
not permitted by the SEC to be included in the Registration Statement solely
due
to comments received by the Company from the SEC.
(c) Information
Requirements.
The
Company may request the Investor to furnish the Company with such information
with respect to the Investor and the Investor’s proposed distribution of
securities being purchased hereunder pursuant to the Registration Statement
as
the Company may from time to time reasonably request in writing or as shall
be
required by law or by the SEC in connection therewith, and the Investor agrees
to furnish the Company with such information.
6. Conditions
to Closing of the Investors.
Each
Investor’s obligations at the Closing are subject to the fulfillment, on or
prior to the Closing Date, of all of the following conditions, any of which
may
be waived in whole or in part by all of the Investors:
(a) Representations
and Warranties.
The
representations and warranties made by the Company in Section 2
hereof
shall have been true and correct when made, and shall be true and correct on
the
Closing Date.
(b) Governmental
Approvals and Filings.
Except
for any notices required
or
permitted to be filed after the Closing Date with certain federal and state
governmental agencies, the Company shall have obtained all governmental
approvals required in connection with the lawful sale and issuance of the Notes
and Warrants.
-7-
(c) Legal
Requirements.
At the
Closing, the sale and issuance by the Company, and the purchase by the
Investors, of the Notes and Warrants shall be legally permitted by all laws
and
regulations to which the Investors or the Company are subject.
(d) Proceedings
and Documents.
All
corporate and other proceedings in connection with the transactions contemplated
at the Closing and all documents and instruments incident to such transactions
shall be reasonably satisfactory in substance and form to the
Investors.
(e) Transaction
Documents.
The
Company shall have duly executed and delivered to the Investors the following
documents:
(i) |
This
Agreement; and
|
(ii) |
Each
Note and Warrant issued hereunder.
|
7. Conditions
to Obligations of the Company.
The
Company’s obligation to issue and sell the Notes and Warrants at the Closing is
subject to the fulfillment, on or prior to the Closing Date, of the following
conditions, any of which may be waived in whole or in part by the
Company:
(a) Representations
and Warranties.
The
representations and warranties made by the Investors in Section 3
and Section 4,
as the
case may be, shall be true and correct when made, and shall be true and correct
on the Closing Date.
(b) Governmental
Approvals and Filings.
Except
for any notices required or permitted to be filed after the Closing Date with
certain federal and state governmental agencies, the Company shall have obtained
all governmental approvals required in connection with the lawful sale and
issuance of the Notes and Warrants.
(c) Legal
Requirements.
At the
Closing, the sale and issuance by the Company, and the purchase by the
Investors, of the Notes and Warrants shall be legally permitted by all laws
and
regulations to which the Investors or the Company are subject.
(d) Purchase
Price.
Each
Investor shall have delivered to the Company the Purchase Price in respect
of
the Note and Warrants being purchased by such Investor referenced in
Section 1(b)
hereof.
8. Miscellaneous.
(a) Waivers
and Amendments.
Any
provision of this Agreement may be amended, waived or modified only upon the
written consent of the Company and Investors holding a Majority in
Interest.
(b) Governing
Law.
This
Agreement and all actions arising out of or in connection with this Agreement
shall be governed by and construed in accordance with the laws of the State
of
New York, without regard to the conflicts of law provisions of the State of
New
York or of any other state.
-8-
(c) Survival.
The
representations, warranties, covenants and agreements made herein shall survive
the execution and delivery of this Agreement.
(d) Successors
and Assigns.
Subject
to the restrictions on transfer described in Sections 8(e)
and 8(f) below,
the rights and obligations of the Company and the Investors shall be binding
upon and benefit the successors, assigns, heirs, administrators and transferees
of the parties.
(e) Registration,
Transfer and Replacement of the Notes.
The
Company will keep, at its principal executive office, books for the registration
and registration of transfer of the Notes. Prior to presentation of any Note
for
registration of transfer, the Company shall treat the Person in whose name
such
Note is registered as the owner and holder of such Note for all purposes
whatsoever, whether or not such Note shall be overdue, and the Company shall
not
be affected by notice to the contrary. Subject to any restrictions on or
conditions to transfer set forth in any Note, the holder of any Note, at its
option, may in person or by duly authorized attorney surrender the same for
exchange at the Company’s chief executive office, and promptly thereafter and at
the Company’s expense, except as provided below, receive in exchange therefor
one or more new Note(s), each in the principal requested by such holder, dated
the date of the Note so surrendered and registered in the name of such Person
or
Persons as shall have been designated in writing by such holder or its attorney
for the same principal amount as the then unpaid principal amount of the Note
so
surrendered. Upon receipt by the Company of evidence reasonably satisfactory
to
it of the ownership of and the loss, theft, destruction or mutilation of any
Note and (a) in the case of loss, theft or destruction, of indemnity
reasonably satisfactory to it; or (b) in the case of mutilation, upon
surrender thereof, the Company, at its expense, will execute and deliver in
lieu
thereof a new Note executed in the same manner as the Note being replaced,
in
the same principal amount as the unpaid principal amount of such Note and dated
the date of such Note.
(f) Assignment
by the Company.
The
rights, interests or obligations hereunder may not be assigned, by operation
of
law or otherwise, in whole or in part, by the Company without the prior written
consent of Investors holding a Majority in Interest.
(g) Entire
Agreement.
This
Agreement together with the other Transaction Documents constitute and contain
the entire agreement among the Company and Investors and supersede any and
all
prior agreements, negotiations, correspondence, understandings and
communications among the parties, whether written or oral, respecting the
subject matter hereof.
(h) Notices.
All
notices, requests, demands, consents, instructions or other communications
required or permitted hereunder shall in writing and faxed, mailed or delivered
to each party as follows: (i) if to a Investor, at such Investor’s address
or facsimile number set forth on the signature page hereto, or at such other
address as such Investor shall have furnished the Company in writing, or
(ii) if to the Company, at 0000 Xxxxxx Xxxxx Xxxxxx Xxxx., Xxxxx 000,
Xxxxxxx Xxxxx, XX 00000, Attn: Xxxxxxxxx Xxxxx, facsimile: (000) 000-0000,
or at
such other address or facsimile number as the Company shall have furnished
to
the Investors in writing. All such notices and communications will be deemed
effectively given the earlier of (i) when received, (ii) when
delivered personally, (iii) one business day after being delivered by
facsimile (with receipt of appropriate confirmation), (iv) one business day
after being deposited with an overnight courier service of recognized standing
or (v) four days after being deposited in the U.S. mail, first class with
postage prepaid.
-9-
(i) Separability
of Agreements; Severability of this Agreement.
The
Company’s agreement with each of the Investors is a separate agreement and the
sale of the Notes and Warrants to each of the Investors is a separate sale.
Unless otherwise expressly provided herein, the rights of each Investor
hereunder are several rights, not rights jointly held with any of the other
Investors. Any invalidity, illegality or limitation on the enforceability of
the
Agreement or any part thereof, by any Investor whether arising by reason of
the
law of the respective Investor’s domicile or otherwise, shall in no way affect
or impair the validity, legality or enforceability of this Agreement with
respect to other Investors. If any provision of this Agreement shall be
judicially determined to be invalid, illegal or unenforceable, the validity,
legality and enforceability of the remaining provisions shall not in any way
be
affected or impaired thereby.
(j) Counterparts.
This
Agreement may be executed in one or more counterparts, each of which will be
deemed an original, but all of which together will constitute one and the same
agreement. Facsimile copies of signed signature pages will be deemed binding
originals.
[Signature
Page Follows]
-10-
The
parties have caused this Agreement to be duly executed and delivered by their
proper and duly authorized officers as of the date and year first written
above.
COMPANY:
|
|
a
Nevada corporation
|
|
By:
|
|
Name:
|
Xxxx
Xxxxxxxx
|
Title:
|
President
|
INVESTOR:
|
|
By:
|
|
Name:
|
|
Title:
|
Note
Amount
|
Warrant
|
||||||
|
$
|
|
(1) |
|
(2)
|
||
|
|||||||
|
|||||||
|
(1) |
All
payments on account of the Note shall be made by check or wire transfer,
payable in United States
dollars, in accordance with wire instructions to be provided by the
Company.
|
(2) |
For
every $3.50 invested in the Company, the Investor shall receive one
(1)
Warrant to purchase
one (1) share of Common Stock.
|